Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127134492 | 12713449 | 2 | F | 2016 | 20160826 | 20160903 | 20160905 | EXP | US-AMGEN-USASP2016116279 | AMGEN | 0.00 | A | Y | 0.00000 | 20160905 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127134492 | 12713449 | 1 | PS | NEULASTA | PEGFILGRASTIM | 1 | Unknown | UNK | U | 125031 | SOLUTION FOR INJECTION | ||||||||
127134492 | 12713449 | 2 | SS | CYTOXAN | CYCLOPHOSPHAMIDE | 1 | Unknown | UNK | 0 | ||||||||||
127134492 | 12713449 | 3 | SS | TAXOTERE | DOCETAXEL | 1 | Unknown | UNK | 0 | ||||||||||
127134492 | 12713449 | 4 | C | REGLAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
127134492 | 12713449 | 5 | C | PHENERGAN | PROMETHAZINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
127134492 | 12713449 | 6 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
127134492 | 12713449 | 7 | C | TAMOXIFEN | TAMOXIFEN | 1 | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127134492 | 12713449 | 1 | Product used for unknown indication |
127134492 | 12713449 | 2 | Product used for unknown indication |
127134492 | 12713449 | 3 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127134492 | 12713449 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127134492 | 12713449 | Abdominal discomfort | |
127134492 | 12713449 | Abdominal pain upper | |
127134492 | 12713449 | Anal ulcer | |
127134492 | 12713449 | Arthralgia | |
127134492 | 12713449 | Bone pain | |
127134492 | 12713449 | Constipation | |
127134492 | 12713449 | Diarrhoea | |
127134492 | 12713449 | Dyspepsia | |
127134492 | 12713449 | Feeling abnormal | |
127134492 | 12713449 | Flatulence | |
127134492 | 12713449 | Headache | |
127134492 | 12713449 | Hot flush | |
127134492 | 12713449 | Hypersensitivity | |
127134492 | 12713449 | Infection | |
127134492 | 12713449 | Injection site pain | |
127134492 | 12713449 | Mouth ulceration | |
127134492 | 12713449 | Nausea | |
127134492 | 12713449 | Pain | |
127134492 | 12713449 | Pruritus | |
127134492 | 12713449 | Pyrexia | |
127134492 | 12713449 | Skin exfoliation |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127134492 | 12713449 | 1 | 2016 | 0 | ||
127134492 | 12713449 | 2 | 20160722 | 0 | ||
127134492 | 12713449 | 3 | 20160722 | 0 |